WHITE HOUSE

Affordable Health Care: President Trump’s Actions on Healthcare and Results


LEGISLATIVE UPDATE

Monday, February 4

Drug Pricing: Senate Finance Committee Chairman Chuck Grassley and Ranking Member Ron Wyden Invite 7 Pharmaceutical Companies to Drug Pricing Hearing

  • Top Senate and House Judiciary Committee Lawmakers Reintroduce Creating and Restoring Equal Access to Equivalent Sample Act
  • House Ways and Means Chairman Richard E. Neal Announces  Hearing Entitled “The Cost of Rising Prescription Drug Prices”

Veterans’ Affairs:Senate Veterans’ Affairs Committee Ranking Member Jon Tester Leads Bipartisan Call for More Transparency and Accountability

Tuesday, February 5

Medicaid: Senators Chuck Grassley and Michael Bennet Reintroduce ACE Kids Act

Health Care Costs: Senate Health Committee Chairman Lamar Alexander Asks for Suggestions to Lower Cost of Health Care

Veterans’ Affairs: Senate Veterans’ Affairs Committee Ranking Member Jon Tester Grills Head of VA Electronic Health Records

HHS: HHS Secretary Azar Praises President Trump’s Vision for Healthcare

Wednesday, February 6

ACA: Chairwoman of the Labor, Health and Human Services, and Education Appropriations Subcommittee Rosa DeLauro (D-CT) Statement on the Impact of the Administration’s Policies Affecting the ACA

  • Energy and Commerce Chairman Frank Pallone Jr. (D-NJ) and Senate Finance Ranking Member Ron Wyden (D-OR) Send Letter GAO on Whether the Trump Administration’s 2018 Guidance on Section 1332 Waivers is Subject to the Congressional Review Act

Healthcare: Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Health Subcommittee Chairwoman Anna Eshoo (D-CA) Announce Strengthening Our Health Care System” Hearing

Thursday, February 7

HHS: Secretary Azar Praises New Drug Industry Steps on Transparency


REGULATORY UPDATE

Monday, February 4

CMS: CMS Proposes Rule that Would Update Proficiency Testing Regulations

  • CMS Announces Approval of National Dialysis Accreditation Commission for Recognition as a National Accrediting Organization

NIH: New Study Links Psoriasis Treatment and Improvement in Heart Artery Disease

Medicare: CMS and CDC Discuss Changes to CLIA

Tuesday, February 5

CDC: NIOSH Announces the Availability of Continuing to Protect the Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018-2015

  • The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention Announces the Availability of National Occupational Research Agenda for Hearing Loss Prevention for Public Comment
  • NIOSH Announces the Availability of the Final National Occupational Research Agenda for Respiratory Health

HRSA: HRSA Announces Plans to Submit an ICR

  • HRSA Submits ICR to the Office of Management and Budget (OMB) for Review and Approval

Wednesday, February 6

CMS: HHS and CMS Propose to Modify an Existing System of Records Subject to the Privacy Act

HHS: OIG and HHS Propose to Amend the Safe Harbor Regulation

HRSA: HRSA Publishes Notice of Petitions Received Under the National Vaccine Injury Compensation Program

CDC: Statement from Dr. Redfield on Ending the HIC Epidemic

FDA: FDA Approves First Therapy for Treatment of Rare Blood Clotting Disorders

  • Pennsylvania Compounder Prohibited from Manufacturing and Distributing Sterile Human and Animal Drug Products

HRSA: HRSA Supports Trump Administrations Plan to end the HIV Epidemic

Thursday, February 7

FDA: FDA Announces Public Advisory Committee Meeting of the Oncologic Drugs Advisory Committee

  • Statement From FDA Commissioner Scott Gottlieb, M.D. on Steps to Strengthen the Agency’s Process for Issuing Public Warnings and Notifications of Recalls
  • FDA Takes New Steps for Improving Security of Drug Supply Chain
  • FDA Takes Action Against 17 Companies for Illegally Selling Products

Friday, February 8

HIV: HHS Office of HIV/AIDS and OHAIDP Leads Development of the Next Iterations of These Two Separate and Distinct National Strategies


UPCOMING EVENTS

NIH
Meeting: Digestive, Kidney and Urological Systems Integrated Review Group; Pathobiology of Kidney Disease Study Section
February 12-13, 2019 8:00 AM – 6:00 PM
Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814

CDC
Meeting: Community Preventive Services Task Forces (CPSTF)
February 13, 2019 8:30 AM – 6:00 PM & February 14, 2019 8:30 AM – 1:00 PM
CDC Edward R. Roybal Campus, Centers for Disease Control and Prevention Headquarters (Building 19), 1600 Clifton Road NE, Atlanta, GA 30329

NIH
Meeting: National Heart, Lung, and Blood Institute Special Emphasis Panel
February 15, 2019 8:00 AM – 4:00 PM
Sheraton Baltimore Washington Airport Hotel, 1100 Old Elkridge Landing Road, Linthicum Heights, MD 21090

National Institute of Neurological Disorders and Stroke
Meeting: National Advisory Neurological Disorders and Stroke Council.
February 14th – 15th 12:30 PM – 6:00 PM
Porter Neuroscience Research Center, Building 35A, Convent Drive, Bethesda, MD 20892

NIH
Meeting: Brain Disorders and Clinical Neuroscience Integrated Review Group; Acute Neural Injury and Epilepsy Study Section
February 21-22, 2019 8:00 AM – 5:00 PM
The Dupont Hotel, 1500 New Hampshire Avenue NW, Washington, DC 20036

NIH
Meeting: Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke
February 24-26, 6:00 PM -12:00 PM
Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814

SAMSA
Meeting: Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council (NAC) Meeting
February 27, 2019 9:00 AM – 5:00 PM
5600 Fishers Lane, Room 5N54, Rockville, MD

CDC
Meeting: Advisory Committee on Immunization Practices (ACIP)
February 27, 2019 8:00 AM – 5:30 PM & February 28, 2019 8:30 AM – 3:30 PM
CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications Center, Building 19, Kent `Oz’ Nelson Auditorium, Atlanta, GA

CDC
Meeting: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel and Occupational Safety and Health Education and Research Centers (ERC)
February 12-13, 2019 8:30 AM – 5:00 PM
Hilton Alexandria Old Town, 1767 King Street, Alexandria, Virginia 22314

FDA
Meeting: Neurological Devices Panel of the Medical Devices Advisory Committee
March 21,2019 8 AM – 5 PM
Hilton Washington, DC North/Gaithersburg, Salons A, B, C and D, 620 Perry Pkwy., Gaithersburg, MD 20877.

NIH
Meeting: Board of Scientific Counselors, NIDDK
October 10-11, 2019 8:00 AM – 6:00 PM
National Institutes of Health, Building 10, Solarium Conference Room 9S233, 10 Center Drive, Bethesda, MD 20892

NIH
Meeting: Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke
June 23-25, 2019 6:00 PM – 12:00 PM
Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814